Study of How Safe and Effective Tarlatamab is in Brain Cancers
Clinical trial NCT06776250 · RECRUITING
Trial details
- NCT number
- NCT06776250
- Sponsor
- University Health Network, Toronto
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-18
- Primary completion
- 2028-03-03
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.